Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Colic
Interventions
BIOLOGICAL

Biogaia L. reuteri DSM 17938

Freeze-dried Lactobacillus reuteri DSM 17938 suspended in oil. Brand Name Active Agent: BioGaia™

BIOLOGICAL

Probiotic Placebo

Description of Placebo: contains same excipients as Active Agent, without the active ingredient

Trial Locations (1)

M5V1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT01541046 - Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic | Biotech Hunter | Biotech Hunter